Updated data from Phase 1 PYNNACLE clinical trial of PC14586 presented at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and…
- Launch of Ghryvelin™ in a number of key countries in the European Economic Area - Approval of Macrilen® in…
Results land amidst surge in drug-resistant organisms and fungal outbreaks, showcase widespread concerns about infection risks in hospitalsBrooklyn, N.Y., Nov.…
Patent Covers Novel Optimization of Care by Remote Monitoring Devices Including Smartwatches Oak Ridge, TN, Nov. 09, 2023 (GLOBE NEWSWIRE)…
STOUGHTON, Mass., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed…
CHARLOTTE, N.C., Nov. 09, 2023 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) will host…
-- Blocking of α5β1 integrin has been shown to improve motor function and increase survival in the SOD1G93A mouse model of…
Jupiter, Florida--(Newsfile Corp. - November 9, 2023) - My Crew Doses Inc., (the "Company" or "MCD"), an American PhD-led brand…
STOCKHOLM, SWEDEN / ACCESSWIRE / November 9, 2023 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR) today announced…
NOT INTENDED FOR DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG-KONG, JAPAN, CANADA, SWITZERLAND,…